Thymosin Beta 4 ( DrugBank: Thymosin beta 4 )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
36	Epidermolysis bullosa	1
53	Sjogren syndrome	1

36. Epidermolysis bullosa

---

Clinical trials : 160 /  Drugs : 195 - (DrugBank : 47) / Drug target genes : 50 - Drug target pathways : 124

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00311766 (ClinicalTrials.gov)	February 2006	4/4/2006	A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa	A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa	Epidermolysis Bullosa	Drug: Thymosin Beta 4;Drug: Placebo	RegeneRx Biopharmaceuticals, Inc.	NULL	Terminated	2 Years	N/A	All	30	Phase 2	United States

53. Sjogren syndrome

---

Clinical trials : 283 /  Drugs : 320 - (DrugBank : 101) / Drug target genes : 56 - Drug target pathways : 181

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01393132 (ClinicalTrials.gov)	March 2011	7/7/2011	Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye	Comparative Study of Thymosin Beta 4 Eye Drops or Vehicle in the Treatment of Patients With Ocular Surface Defects Due to Severe Dry Eye	Dry Eye;Sjogren's Syndrome;Graft vs. Host Disease	Drug: Thymosin Beta 4 eye drops;Drug: Vehicle Control	Michigan Cornea Consultants, PC	Kresge Eye Institute	Completed	18 Years	90 Years	All	9	Phase 2	United States